Mises Daily
Author:
Gilbert Berdine, MD
Online Publish Date:
of four. That is the minimal cost of a fully homogenized national health-insurance policy where everything is covered, everyone is covered, and there are no preexisting is no different. A free-market insurance industry would be allowed to sell policies against the treatment of leukemia. This treatment is catastrophically serve only to grant monopoly privileges, thereby raising costs and decreasing innovation. A common defense of pharmaceutical patents is that people would not